Lastly, the survival of breast cancer patients was significantly influenced by the high expression of TUBA1A in Luminal B patients and MAP1B in Luminal A patients, which corroborated the importance of these markers and the expression of genes and proteins related to cell motility. This evidence concerns the gene MAP1B and breast cancer.